We are live on
!
Find out more
EPRS
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
EPRS
Delisted
EPRS was delisted on the 3rd of August, 2016.
45 hedge funds and large institutions have $41.3M invested in EPIRUS BIOPHARMACEUTICALS INC COM in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
114% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 7
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
10% more funds holding
Funds holding: 41 → 45 (+4)
36% less capital invested
Capital invested by funds: $64.9M → $41.3M (-$23.6M)
99% less call options, than puts
Call options by funds: $3K | Put options by funds: $388K
Holders
45
Holders Change
+4
Holders Change %
+9.76%
% of All Funds
1.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
15
Reduced
7
Closed
6
Calls
$3K
Puts
$388K
Net Calls
-$385K
Net Calls Change
+$109K
Top Buyers
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$10.3M |
| 2 |
B
Bailard
Foster City,
California
|
-$1.56M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$355K |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$254K |
| 5 |
JCG
JHL Capital Group
Chicago,
Illinois
|
-$243K |
